Sabra Healthcare REIT Inc (SBRA)

Currency in USD
19.06
-0.16(-0.83%)
Closed·
19.32+0.27(+1.42%)
·
High dividend Yield
SBRA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.0119.29
52 wk Range
15.6019.97
Key Statistics
Prev. Close
19.22
Open
19.09
Day's Range
19.01-19.29
52 wk Range
15.6-19.97
Volume
3.84M
Average Volume (3m)
2.85M
1-Year Change
3.42%
Book Value / Share
11.78
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBRA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.77
Upside
+8.97%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 15 consecutive years

Sabra Healthcare REIT Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Sabra Healthcare REIT Inc Company Profile

As of September 30, 2025, Sabra's investment portfolio included 363 real estate properties held for investment (consisting of (i) 217 skilled nursing/transitional care facilities, (ii) 32 senior housing communities ("senior housing - leased"), (iii) 83 senior housing communities operated by third-party property managers pursuant to property management agreements ("senior housing - managed"), (iv) 16 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 14 investments in loans receivable (consisting of three mortgage loans and 11 other loans), four preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2025, Sabra's real estate properties held for investment included 36,998 beds/units, spread across the United States and Canada.

Sabra Healthcare REIT Inc SWOT Analysis


Healthcare REIT Leade
Sabra Health Care REIT, a $4.33B market cap company, shows resilience in post-pandemic landscape with 10.76% revenue growth and strong portfolio performance
Financial Outlook
Core FFO guidance of $1.43-$1.46 per share for 2025, with AFFO projected at $1.47-$1.50, showcasing stable financial performance and growth potential
Strategic Expansion
Explore Sabra's $200M pipeline of SHOP deals and its focus on senior housing assets, potentially driving multiple expansion and capitalizing on market demand
Analyst Perspectives
Price targets of $20 from Citizens Bank and JMP Securities highlight positive outlook, with potential upside from current trading levels below fair value
Read full SWOT analysis

Sabra Healthcare REIT Inc Earnings Call Summary for Q3/2025

  • Sabra Healthcare REIT reported Q3 2025 EPS of $0.09 (50% below forecast), while revenue reached $190.04M (1.59% above expectations); stock rose 2.14% post-earnings but fell 1.43% premarket.
  • The company increased its senior housing exposure from 20% to 26%, investing $237M in Q3, with a strategic target of 40% allocation supported by favorable demographic trends.
  • Cash NOI from managed senior housing portfolio rose to $30.1M from $25.3M in the previous quarter, with normalized FFO at $0.36 per share and AFFO at $0.38 per share.
  • Management maintains positive outlook with 2025 normalized FFO guidance of $1.46 per share and AFFO guidance of $1.50 per share, projecting mid-teens full-year same-store cash NOI growth.
  • CEO Rick Matros highlighted that 'demographics that everybody's been waiting for for three decades are really kicking in,' supporting the company's strategic shift toward senior housing.
Last Updated: 06/11/2025, 20:38
Read Full Transcript

Compare SBRA to Peers and Sector

Metrics to compare
SBRA
Peers
Sector
Relationship
P/E Ratio
27.1x17.1x8.8x
PEG Ratio
0.35−0.820.01
Price/Book
1.7x1.1x0.9x
Price / LTM Sales
6.4x4.5x4.0x
Upside (Analyst Target)
10.0%14.8%15.6%
Fair Value Upside
Unlock−12.7%0.3%Unlock

Analyst Ratings

6 Buy
9 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 20.77
(+8.97% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Buy21.00+10.18%20.00MaintainNov 25, 2025
UBS
Hold20.00+4.93%-New CoverageNov 18, 2025
Wells Fargo
Buy20.00+4.93%21.00MaintainOct 21, 2025
Citizens
Buy22.00+15.42%-MaintainOct 21, 2025
Cantor Fitzgerald
Hold20.00+4.93%-New CoverageOct 01, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.73%
Dividend Yield
6.30%
Industry Median 5.15%
Annualised payout
1.20
Paid quarterly
5-Years Growth
-4.36%
Growth Streak

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
0.09 / 0.18
Revenue / Forecast
190.04M / 187.06M
EPS Revisions
Last 90 days

SBRA Income Statement

People Also Watch

45.93
OHI
+0.55%
203.87
WELL
+0.97%
66.06
FISV
-1.33%
28.00
VICI
-1.06%
17.18
DOC
-0.61%

FAQ

What Is the Sabra (SBRA) Premarket Price Today?

The Sabra (SBRA) premarket price is 19.18. Premarket price change units: -0.04. Premarket percentage change: -0.21%. Premarket volume: 1,300.00. Current date: 05 Dec 2025. Previous close: 19.22

What Stock Exchange Does Sabra Trade On?

Sabra is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Sabra?

The stock symbol for Sabra is "SBRA."

What Is the Sabra (SBRA) Afterhours Price Today? (Afterhours variable test: 19.32) Current Date: 05 Dec 2025

After hours price: 19.32. After hours price change (units): 0.27. Price change percentage: 1.42%

What Is the Sabra Market Cap?

As of today, Sabra market cap is 4.75B.

What Is Sabra's Earnings Per Share (TTM)?

The Sabra EPS (TTM) is 0.73.

When Is the Next Sabra Earnings Date?

Sabra will release its next earnings report on 23 Feb 2026.

From a Technical Analysis Perspective, Is SBRA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sabra Stock Split?

Sabra has split 0 times.

How Many Employees Does Sabra Have?

Sabra has 50 employees.

What is the current trading status of Sabra (SBRA)?

As of 05 Dec 2025, Sabra (SBRA) is trading at a price of 19.06, with a previous close of 19.22. The stock has fluctuated within a day range of 19.01 to 19.29, while its 52-week range spans from 15.60 to 19.97.

What Is Sabra (SBRA) Price Target According to Analysts?

The average 12-month price target for Sabra is USD20.76923, with a high estimate of USD22 and a low estimate of USD20. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +8.97% Upside potential.

What Is the SBRA Premarket Price?

SBRA's last pre-market stock price is 19.18. The pre-market share volume is 1,300.00, and the stock has decreased by -0.04, or -0.21%.

What Is the SBRA After Hours Price?

SBRA's last after hours stock price is 19.32, the stock has decreased by 0.27, or 1.42%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.